Qube Research & Technologies (QRT)
FHTX icon

Qube Research & Technologies (QRT)’s Foghorn Therapeutics FHTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$389K Buy
81,278
+28,021
+53% +$154K ﹤0.01% 2802
2025
Q4 		$288K Buy
+53,257
New +$241K ﹤0.01% 2959
2025
Q2 		– Sell
-51,098
Closed -$187K – 3669
2025
Q1 		$187K Buy
51,098
+1,455
+3% +$6.63K ﹤0.01% 2891
2024
Q4 		$234K Buy
49,643
+29,094
+142% +$212K ﹤0.01% 2792
2024
Q3 		$191K Buy
+20,549
New +$149K ﹤0.01% 2600

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Qube Research & Technologies (QRT)'s FHTX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Foghorn Therapeutics (FHTX) stake by 53% in Q1 2026, buying an estimated $154K and bringing the position to 81,278 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2802.

Qube Research & Technologies (QRT) first reported a position in FHTX in Q3 2024 and has held it in 5 quarters since. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 81,278 shares of Foghorn Therapeutics worth $389K as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 28,021 Foghorn Therapeutics shares in Q1 2026, an estimated $154K.
  • Foghorn Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2802 holding.
  • Qube Research & Technologies (QRT) first reported a position in Foghorn Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.